Cat.#: ACPP-1525
| Despition | PCDHGC4 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1122 | Synthetic Membrane Nanoparticle Human Adenosine Receptor A2a Protein (AC1122) | 50 µg | inquiry |
| ACPP-1340 | PDE7A Blocking Peptide (AC1340) | 250 µg | inquiry |
| ACPP-1345 | DISC1 Blocking Peptide (AC1345) | 250 µg | inquiry |
| ACPP-1145 | Recombinant Mouse CD34 Protein (Fc Tag) (AC1145) | 50 µg | inquiry |
| ACPP-1008 | Recombinant Human Siglec 7 Protein (6×His Tag) (AC1008) | 50 µg | inquiry |
| ACPP-1566 | Human STMN1 Protein (AC1566) | 5 µg | inquiry |
| ACPP-1065 | Recombinant Human Prostate Specific Antigen Protein (Fc Tag) (AC1065) | 50 µg | inquiry |
| ACPP-1482 | Human FGFR1 Protein (AC1482) | 2 µg | inquiry |
| ACPP-1116 | Recombinant Human L1CAM Protein (6×His Tag) (AC1116) | 50 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.